HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer

- Brunton, Holly, Caligiuri, Giuseppina, Wright, Derek W., Paulus-Hock, Viola, Nixon, Colin, Thomson, Gemma, Jamieson, Nigel B., McGregor, Grant A., Evers, Lisa, McKay, Colin J., Gulati, Aditi, Cunningham, Richard, Upstill-Goddard, Rosie, Bailey, Ulla-Maja, Scarlett, Christopher J., Garner, Ian M., Nourse, Craig, Wong, Rachel, Dreyer, Stephan, Jones, Marc, Moran-Jones, Kim

Targeting mTOR dependency in pancreatic cancer

- Morran, Douglas C., Wu, Jianmin, Australian Pancreatic Cancer Genome Initiative,, Oien, Karin A., McKay, Colin J., Carter, C. Ross, Gillen, Gerry, Champion, Sue, Pimlott, Sally L., Anderson, Kurt I., Evans, T. R. Jeffry, Grimmon , Sean M., Jamieson, Nigel B., Biankin, Andrew V., Samson, Owen J., Morton, Jennifer P., Mrowinska, Agata, Kalna, Gabriela, Karim, Saadia A., Au, Amy Y. M., Scarlett, Christopher J., Chang, David K., Pajak, Malgorzata Z.

Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater

- Chang, David K., Jamieson, Nigel B., Nagrial, Adnan M., Chantrill, Lorraine A., Chin, Venessa T., Pinho, Andreia V., Rooman, Ilse, Cowley, Mark J., Wu, Jianmin, Mead, R. Scott, Colvin, Emily K., Samra, Jaswinder S., Johns, Amber L., Corbo, Vincenzo, Bassi, Claudio, Falconi, Massimo, Lawlor, Rita T., Crippa, Stefano, Sperandio, Nicola, Bersani, Samantha, Dickson, Euan J., Mohamed, Mohamed A. A., Oien, Karin A., Scarlett, Christopher J., Foulis, Alan K., Musgrove, Elizabeth A., Sutherland, Robert L., Kench, James G., Carter, C. Ross, Gill, Anthony J., Scarpa, Aldo, McKay, Colin J., Biankin, Andrew V., Pajic, Marina, Chou, Angela, Pinese, Mark, Humphris, Jeremy L., Jones, Marc D., Toon, Christopher